Michael J. Farrell - Nov 25, 2024 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Nov 25, 2024
Transactions value $
$7,745,134
Form type
4
Date filed
11/27/2024, 03:19 PM
Previous filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Gift $0 -2K -48.9% $0.00 2.09K Nov 27, 2024 Lisette and Michael Farrell Family Trust F1
transaction RMD ResMed Common Stock Gift $0 +2K $0.00 2K Nov 27, 2024 Lisette and Michael Farrell Foundation F2
transaction RMD ResMed Common Stock Sale -$499K -2K -100% $249.67 0 Nov 27, 2024 Lisette and Michael Farrell Foundation
holding RMD ResMed Common Stock 455K Nov 25, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $8.24M +33K $249.56 33K Nov 25, 2024 ResMed Common Stock 33K $249.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gift of shares transferred to The Lisette and Michael Farrell Family Foundation, Mr. Farrell retains dispositive power over remaining shares.
F2 Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.
F3 Represents date options first become exercisable. Options vest 1/3 per year.